Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types
CA 2365645 A1 · Owner: The Trustees Of Columbia University · Inventors: Fisher, Paul B.; Gopalkrishnan, Rahul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a vector comprising Protein Translation Peptide Elongation Factor-1 .alpha. promoter and nucleic acids encoding reverse tetracycline controlled transactivator wherein the expression of said , transactivator is under the control of Protein Translation Peptide Elongation Factor-1 .alpha. promoter. In addition the invention provides a method of , generating a reverse tetracycline controlled transactivator expression system for inducible tetracycline regulated gene expression comprising: (a) isolation of a DNA fragment encoding the reverse tetracycline controlled transactivator by restriction enzyme digestion, (b) generation of Protein Translation Peptide …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 15, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 15, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 15, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.